Real-time enrollment status for this rsv respiratory syncytial virus clinical trial
Current Status
Recruiting
Checked: July 21, 2026 at 10:13 PM UTC
| NCT Number | NCT07717840 |
| Recruiting Status | Recruiting |
| Condition | RSV Respiratory Syncytial Virus |
| Phase | PHASE1 |
| Target Enrollment | 160 participants |
| Active Locations | 6 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | July 21, 2026 (22 hours ago) |
As of July 21, 2026: Clinical trial NCT07717840 is currently recruiting participants. This phase1 study for rsv respiratory syncytial virus is actively seeking new participants at 6 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07717840 is actively recruiting participants as of July 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07717840 was last updated 22 hours ago (July 21, 2026). HelloStudys verifies this status automatically.